سوق التحويل الجيني في آسيا والمحيط الهادئ، حسب النوع (التحويل الجيني المؤقت، التحويل الجيني المستقر)، الطرق (الطرق غير الفيروسية، الطرق الفيروسية)، طرق التحويل الجيني باستخدام كريسبر (الطرق غير الفيروسية، الطرق الفيروسية)، المنتجات (الكاشف والمجموعات، الجهاز، البرمجيات)، الكائن الحي (خلايا الثدييات، النباتات، الفطريات، الفيروسات، البكتيريا)، أنواع الجزيئات (الحمض النووي البلازميدي، الحمض النووي الريبي المتداخل الصغير (siRNA)، البروتينات، أوليجونوكليوتيدات الحمض النووي، مجمعات الريبوزوكليوبروتين (RNPs)، أخرى)، التطبيق (تطبيق في المختبر، تطبيق في الجسم الحي، الإنتاج البيولوجي، أخرى)، المرحلة (البحث، ما قبل السريرية، المراحل السريرية، التجارية)، المستخدم النهائي (الشركات الصيدلانية الحيوية، منظمات أبحاث العقود (CROs)، منظمة التصنيع التعاقدي/ منظمة تطوير وتصنيع العقود (CMOs/CDMOs)، الأوساط الأكاديمية، المستشفيات، المختبرات السريرية، أخرى)، قناة التوزيع (العطاء المباشر، مبيعات التجزئة، أخرى)، اتجاهات الصناعة والتوقعات حتى عام 2028 في الدول (اليابان، الصين، الهند، كوريا الجنوبية، أستراليا، سنغافورة، ماليزيا، تايلاند، الفلبين، بقية دول آسيا والمحيط الهادئ)
تحليل السوق والرؤى: سوق النقل الجيني في منطقة آسيا والمحيط الهادئ
من المتوقع أن يكتسب سوق التحويل الجيني نموًا في السوق في الفترة المتوقعة من 2021 إلى 2028. تحلل شركة Data Bridge Market Research أن السوق ينمو بمعدل نمو سنوي مركب بنسبة 11.5٪ في الفترة المتوقعة من 2021 إلى 2028 ومن المتوقع أن يصل إلى 309.85 مليون دولار أمريكي بحلول عام 2028. تعد التحويلات واسعة النطاق المستخدمة في البحث السريري واستخدام المستحضرات الصيدلانية الحيوية في إنتاج البروتينات من المحركات الرئيسية التي دفعت الطلب على سوق التحويل الجيني في الفترة المتوقعة.
تُستخدم طريقة التحويل الجيني لإدخال منتجات الحمض النووي الريبوزي أو الحمض النووي الريبوزي أو البروتين في الخلايا لتغيير النمط الظاهري والنمط الجيني للكائن الحي. تتضمن طريقة التحويل الجيني نقل جين جديد أو نقل بنية جينية مثل التكرارات القصيرة المتناظرة المنتظمة (CRISPR) لأغراض تحرير الجينوم. للتحويل الجيني تطبيقات واسعة في مجال العلاج المناعي والعلاج الجيني وعلاج الخلايا وغيرها. يتضمن التحويل الجيني كل من التحويل الجيني غير الفيروسي والفيروسي. يمكن للطرق الكيميائية والفيزيائية تحقيق التحويل الجيني غير الفيروسي.
إن ارتفاع معدل انتشار الأمراض المزمنة يعمل كمحرك لنمو سوق التحويل الجيني. كما تعمل التكلفة العالية للأدوات كمقيد لنمو سوق التحويل الجيني. كما يعمل استكشاف الأسواق الناشئة كفرصة لنمو سوق التحويل الجيني. كما تعمل إجراءات الموافقة الطويلة كتحدي لنمو سوق التحويل الجيني.
يقدم تقرير سوق التحويل الجيني تفاصيل عن حصة السوق والتطورات الجديدة وتحليل خط أنابيب المنتجات وتأثير اللاعبين المحليين والمحليين في السوق وتحليل الفرص من حيث جيوب الإيرادات الناشئة والتغييرات في لوائح السوق وموافقات المنتجات والقرارات الاستراتيجية وإطلاق المنتجات والتوسعات الجغرافية والابتكارات التكنولوجية في السوق. لفهم التحليل وسيناريو سوق التحويل الجيني، اتصل بـ Data Bridge Market Research للحصول على موجز محلل، وسيساعدك فريقنا في إنشاء حل لتأثير الإيرادات لتحقيق هدفك المنشود.
نطاق سوق التحويل الجيني وحجم السوق
يتم تقسيم سوق التحويل الجيني على أساس النوع والطرق وطرق التحويل الجيني باستخدام CRISPR والمنتجات والكائنات الحية وأنواع الجزيئات والتطبيق والمرحلة والمستخدم النهائي وقناة التوزيع. يساعدك النمو بين القطاعات على تحليل جيوب النمو والاستراتيجيات المتخصصة للتعامل مع السوق وتحديد مجالات التطبيق الأساسية لديك والاختلاف في الأسواق المستهدفة.
- على أساس النوع، يتم تقسيم سوق التحويل الجيني إلى التحويل الجيني المؤقت والتحويل الجيني المستقر. في عام 2021، يهيمن قطاع التحويل الجيني المؤقت حيث تحصل هذه الطريقة على نتائج التحويل الجيني في غضون 3-7 أيام مع معدلات كفاءة تحويل جينية عالية.
- على أساس الأساليب، يتم تقسيم سوق التحويل إلى أساليب غير فيروسية وأساليب فيروسية. في عام 2021، تهيمن شريحة الأساليب غير الفيروسية على جميع أنواع التحويل بما في ذلك التحويل باستخدام CRISPR (تكرارات قصيرة منتظمة متباعدة) حيث توفر هذه الأساليب كفاءة تحويل عالية وتتغلب على فرص العدوى التي تسببها أساليب التحويل الفيروسية.
- على أساس طرق نقل الجينات باستخدام تقنية CRISPR، يتم تقسيم سوق نقل الجينات إلى طرق غير فيروسية وطرق فيروسية. في عام 2021، تهيمن شريحة الطرق غير الفيروسية على نقل الجينات باستخدام تقنية CRISPR (تكرارات قصيرة منتظمة متباعدة) لأنها تتيح توصيل تسلسلات CRISPR بكفاءة إلى خطوط الخلايا المستهدفة.
- على أساس المنتجات، يتم تقسيم سوق التحويل الجيني إلى كواشف ومجموعات وأدوات وبرامج. في عام 2021، تهيمن فئة الكواشف والمجموعات على السوق حيث تُستخدم لتعزيز فعالية عملية التحويل الجيني في تجارب وراثية مختلفة.
- على أساس الكائن الحي، يتم تقسيم سوق النقل الجيني إلى خلايا الثدييات والنباتات والفطريات والفيروسات والبكتيريا . في عام 2021، تهيمن شريحة خلايا الثدييات حيث تُستخدم خلايا الثدييات على نطاق واسع لإنتاج الأجسام المضادة وحيدة النسيلة والبروتينات واليوروكيناز والهرمون المنبه للجريب وغيرها من المنتجات مقارنة بأنواع أخرى من خطوط الخلايا.
- على أساس أنواع الجزيئات، يتم تقسيم سوق النقل الجيني إلى DNA البلازميدي، وRNA المتداخل الصغير (siRNA)، والبروتينات، ونوكليوتيدات DNA، ومجمعات الريبونوكليوبروتين (RNPs) وغيرها. في عام 2021، يهيمن قطاع DNA البلازميدي حيث تم تطوير عدد كبير من تقنيات النقل الجيني في البداية لنقل DNA البلازميدي إلى الخلايا.
- على أساس التطبيق، يتم تقسيم سوق النقل الجيني إلى تطبيق في المختبر، وتطبيق في الجسم الحي، والإنتاج الحيوي وغيرها. في عام 2021، يهيمن قطاع التطبيقات في المختبر لأنه يوفر توصيل جزيئات الحمض النووي إلى الخلايا المزروعة والتي تلعب دورًا حاسمًا في البحث وكذلك في الإنتاج التجاري للجزيئات.
- على أساس المرحلة، يتم تقسيم سوق التحويل الجيني إلى مرحلة بحثية ومرحلة ما قبل السريرية ومرحلة سريرية ومرحلة تجارية. في عام 2021، يهيمن قطاع البحث بسبب الطلب المتزايد على التعبير الجيني عبر صناعة البيولوجيا الاصطناعية والتطبيقات الأخرى.
- على أساس المستخدم النهائي، يتم تقسيم سوق التحويل الجيني إلى شركات الأدوية الحيوية ، ومنظمات الأبحاث التعاقدية (CROs)، ومنظمات التصنيع التعاقدي/منظمات التطوير والتصنيع التعاقدية (CMOs/CDMOs)، والأوساط الأكاديمية، والمستشفيات، والمختبرات السريرية وغيرها. في عام 2021، احتل قطاع الأدوية الحيوية أكبر حصة في السوق بسبب الطلب المتزايد على تحسين الكفاءة والسرعة لإنتاج خطوط الخلايا المرغوبة.
- على أساس قناة التوزيع، يتم تقسيم سوق التحويل إلى العطاءات المباشرة ومبيعات التجزئة وغيرها. في عام 2021، يهيمن قطاع العطاءات المباشرة لأنه المصدر الأساسي للشراء عبر المستخدمين النهائيين المختلفين.
تحليل على مستوى الدولة لسوق النقل الجيني في منطقة آسيا والمحيط الهادئ
يتم تحليل سوق النقل الجيني وتوفير معلومات حجم السوق على أساس البلد والنوع والأساليب وطرق النقل CRISPR والمنتجات والكائن الحي وأنواع الجزيء والتطبيق والمرحلة والمستخدم النهائي وقناة التوزيع كما هو مذكور أعلاه.
الدول التي يغطيها تقرير سوق النقل الجيني في منطقة آسيا والمحيط الهادئ هي اليابان والصين والهند وكوريا الجنوبية وأستراليا وسنغافورة وماليزيا وتايلاند والفلبين وبقية دول آسيا والمحيط الهادئ.
من المتوقع أن ينمو قطاع التحويل الجيني العابر في منطقة آسيا والمحيط الهادئ بأعلى معدل نمو في الفترة المتوقعة من 2021 إلى 2028 بسبب استخدام المستحضرات الصيدلانية الحيوية في إنتاج البروتينات. تقود الصين نمو سوق التحويل الجيني في منطقة آسيا والمحيط الهادئ ويهيمن قطاع التحويل الجيني العابر في البلاد بسبب مستويات الاستثمار المتزايدة والطلب المتزايد على الأجسام المضادة وحيدة النسيلة. ينمو قطاع التحويل الجيني العابر في اليابان في سوق التحويل الجيني في منطقة آسيا والمحيط الهادئ بسبب الطلب المتزايد على العلاج الفعال لمستويات الاضطرابات الوراثية المتزايدة.
كما يوفر قسم الدولة في التقرير عوامل التأثير الفردية على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. تعد نقاط البيانات مثل المبيعات الجديدة ومبيعات الاستبدال والتركيبة السكانية للدولة والقوانين التنظيمية ورسوم الاستيراد والتصدير من بين المؤشرات الرئيسية المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية في منطقة آسيا والمحيط الهادئ والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية وتأثير قنوات المبيعات أثناء تقديم تحليل توقعات لبيانات الدولة.
استكشاف الأسواق الناشئة ومستويات الاستثمار المتزايدة تعزز سوق التحويل الجيني
يوفر لك سوق التحويل الجيني أيضًا تحليلًا تفصيليًا للسوق لكل دولة من حيث نمو صناعة التحويل الجيني مع مبيعات أدوية التحويل الجيني وتأثير التقدم في تكنولوجيا التحويل الجيني والتغييرات في السيناريوهات التنظيمية مع دعمها لسوق التحويل الجيني. تتوفر البيانات للفترة التاريخية من 2011 إلى 2019.
تحليل المشهد التنافسي وحصة سوق النقل الجيني
يوفر المشهد التنافسي لسوق التحويل الجيني تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، ومواقع الإنتاج والمرافق، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وخطوط أنابيب تجارب المنتجات، وموافقات المنتجات، وبراءات الاختراع، وعرض المنتج ونطاقه، وهيمنة التطبيق، ومنحنى شريان الحياة التكنولوجي. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركة فيما يتعلق بسوق التحويل الجيني.
الشركات الرئيسية التي تتعامل في تقرير سوق النقل الجيني في منطقة آسيا والمحيط الهادئ هي Mirus Bio LLC وPromega Corporation وBio-Rad Laboratories, Inc. وMerck KGaA وLonza وMaxCyte, Inc. وSBS Genetech وCytiva وR&D Systems, Inc. وTakara Bio Inc. وThermo Fisher Scientific Inc. وRoche Molecular Systems, Inc. (شركة تابعة لشركة F. Hoffmann-La Roche Ltd) وQIAGEN وOriGene Technologies, Inc. وTwist Bioscience وBeckman Coulter, Inc. (شركة تابعة لشركة Danaher) وCodexis وSignaGen Laboratories من بين اللاعبين المحليين الآخرين. يفهم محللو DBMR نقاط القوة التنافسية ويوفرون تحليلًا تنافسيًا لكل منافس على حدة.
كما تقوم الشركات في جميع أنحاء العالم بإطلاق العديد من المنتجات وتوقيع العديد من الاتفاقيات التي تعمل أيضًا على تسريع سوق النقل الجيني.
على سبيل المثال،
- في نوفمبر 2020، تعاونت شركة Thermo Fisher Scientific Inc. مع جامعة نورث إيسترن لتعزيز الابتكار والقدرات في صناعة الأدوية الحيوية والعلاجات الجينية والخلوية. وتشارك الشركة باستمرار في تصنيع الكواشف والتقنيات المبتكرة والمتقدمة لتوفير الحساسية والدقة للتجارب الجارية وتطوير الأدوية. وبالتالي سمح هذا التعاون للشركة بدفع نمو الكواشف والأدوات القيمة والفعالة للغاية المستخدمة في إجراء النقل الجيني.
إن التعاون وإطلاق المنتج وتوسيع الأعمال والجوائز والتقدير والمشاريع المشتركة والاستراتيجيات الأخرى من قبل اللاعبين في السوق تعمل على تعزيز سوق الشركة في سوق النقل الجيني مما يوفر أيضًا فائدة للمنظمة لتحسين عرضها للنقل الجيني.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC TRANSFECTION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 TOTAL ADDRESSABLE MARKET
4.1.1 BY METHOD/MODALITY
4.1.2 BY END USER
4.1.3 BY APPLICATION
4.1.4 BY STAGE
4.2 EARLY AND LATE STAGE CELL LINE DEVELOPMENT FOR BIOPHARMA AND VIRAL VECTOR PRODUCTION FOR GENE THERAPY
4.2.1 THE LIST OF APPROVED ANTIBODIES PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS AND LIST OF SELECTABLE MARKERS USED IN MAMMALIAN EXPRESSION VECTORS
5 REGULATORY FRAMEWORK
5.1 EUROPEAN UNION REGULATORY SCENARIO
5.2 U.S. REGULATORY SCENARIO
5.3 JAPAN REGULATORY SCENARIO
5.4 CHINA REGULATORY SCENARIO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES
6.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS
6.1.3 GROWING DEMAND OF CHIMERIC GENES
6.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH
6.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS
6.2 RESTRAINTS
6.2.1 HIGH COST OF TRANSFECTION PRODUCTS
6.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS
6.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE
6.3 OPPORTUNITIES
6.3.1 EXPLORATION OF EMERGING MARKET
6.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.3 INCREASING GOVERNMENT SUPPORT
6.3.4 SURGING LEVEL OF INVESTMENT
6.4 CHALLENGES
6.4.1 LONG APPROVAL PROCEDURE
6.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS ASSOCIATED TRANSFECTION
6.4.3 LACK OF TRAINED PROFESSIONALS
7 COVID-19 IMPACT OF ASIA-PACIFIC TRANSFECTION MARKET IN HEALTHCARE INDUSTRY
7.1 OVERVIEW
7.2 IMPACT ON THE PRICE
7.3 IMPACT ON DEMAND
7.4 IMPACT ON SUPPLY CHAIN
7.5 STRATEGIC INITIATIVE BY MANUFACTURERS
7.6 CONCLUSION
8 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPE
8.1 OVERVIEW
8.2 TRANSIENT TRANSFECTION
8.2.1 BY STAGE
8.2.1.1 RESEARCH
8.2.1.2 PRECLINICAL
8.2.1.3 CLINICAL PHASES
8.2.1.4 COMMERCIAL
8.2.2 BY PRODUCT
8.2.2.1 REAGENT & KITS
8.2.2.2 INSTRUMENTS
8.2.2.3 SOFTWARE
8.3 STABLE TRANSECTION
8.3.1 BY STAGE
8.3.1.1 RESEARCH
8.3.1.2 PRECLINICAL
8.3.1.3 CLINICAL PHASES
8.3.1.4 COMMERCIAL
8.3.2 BY PRODUCT
8.3.2.1 REAGENT & KITS
8.3.2.2 INSTRUMENTS
8.3.2.3 SOFTWARE
9 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS
9.1 2.1 OVERVIEW
9.2 NON- VIRAL METHODS
9.2.1 CHEMICAL
9.2.1.1 Lipofection Method
9.2.1.2 Calcium Phosphate Precipitation Method
9.2.1.3 Polyethylenimine (PEI)–DNA Condensation Method
9.2.1.4 Others
9.2.2 PHYSICAL
9.2.2.1 Electroporation
9.2.2.2 Direct Microinjection
9.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
9.2.2.4 Magnetofection
9.2.2.5 Sonoporation
9.2.2.6 Others
9.3 VIRAL METHODS
9.3.1 RETROVIRUS TRANSFECTION
9.3.2 ADENOVIRUS TRANSFECTION
9.3.3 LENTIVIRUS TRANSFECTION
9.3.4 OTHERS
10 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS
10.1 OVERVIEW
10.2 NON- VIRAL METHODS
10.2.1 CHEMICAL
10.2.1.1 Lipofection Method
10.2.1.2 Calcium Phosphate Precipitation Method
10.2.1.3 Polyethylenimine (PEI)–DNA Condensation Method
10.2.1.4 Others
10.2.2 PHYSICAL
10.2.2.1 Electroporation
10.2.2.2 Direct Microinjection
10.2.2.3 Biolistic Particle Delivery/ Particle Bombardment
10.2.2.4 Magnetofection
10.2.2.5 Sonoporation
10.2.2.6 Others
10.3 VIRAL METHODS
10.3.1 RETROVIRUS TRANSFECTION
10.3.2 ADENOVIRUS TRANSFECTION
10.3.3 LENTIVIRUS TRANSFECTION
10.3.4 OTHERS
11 ASIA-PACIFIC TRANSFECTION MARKET, BY PRODUCTS
11.1 OVERVIEW
11.2 REAGENTS & KITS
11.2.1 CATIONIC LIPIDS
11.2.1.1 Liposomal Reagents
11.2.1.1.1 L-Dioleoyl Phosphatidylethanolamine (DOPE)
11.2.1.1.2 DOTAP [1,2-Dioleoyloxy-3-Trimethylammonium Propane]
11.2.1.1.3 DOTMA [N-[1(2,3-Dioleoyloxy)Propyl]-N,N,N-Trimethylammonium Chloride]
11.2.1.1.4 Others
11.2.1.2 Non-Liposomal Reagents
11.2.1.2.1 DNA Transfection Reagent
11.2.1.2.2 siRNA Transfection Reagent
11.2.1.2.3 Others
11.2.2 CATIONIC POLYMER
11.2.2.1 DEAE-Dextran
11.2.2.2 Polybrene
11.2.2.3 Polyethyleneimine
11.2.2.4 Dendrimers
11.2.2.5 Others
11.2.3 NANOPARTICLES
11.2.3.1 Systemic Intravenous Injection
11.2.3.2 Direct Intratumoral Injection
11.2.4 KITS
11.2.4.1 Transporter Transfection Reagent
11.2.4.2 GMP Transfection Reagent
11.2.4.3 Neon Electroporation
11.2.4.4 Cellfectin Ii Transfection Reagent
11.2.4.5 DMRIE-C Transfection Reagent
11.2.4.6 Lipofectamine Transfection Reagent
11.2.4.7 Lipofectin Transfection Reagent
11.2.4.8 Oligofectamine Transfection Reagent
11.2.4.9 Optifect Transfection Reagent
11.2.4.10 Cell Specific Transfection Reagent
11.2.4.11 Gene Gun Kit
11.2.4.12 Plasmid Transfection Reagent
11.2.4.13 Others
11.2.5 CUVETTE CHAMBER
11.2.6 OTHERS
11.3 INSTRUMENT
11.3.1 ELECTROPORATION SYSTEM
11.3.1.1 Neon Transfection System
11.3.1.2 Others
11.3.2 ELECTRO-CELL FUSION GENERATOR
11.3.3 ELECTRO-KINETIC TRANSFECTION SYSTEM
11.3.4 HEPTA SYSTEM
11.3.5 TUBING PREP STATION
11.3.6 RT-PCR
11.3.7 GUN SYSTEM
11.3.8 MICROPLATE READER
11.3.9 SONOPORATION SYSTEM
11.3.10 MICROSCOPES
11.3.11 OTHERS
12 ASIA-PACIFIC TRANSFECTION MARKET, BY ORGANISM
12.1 OVERVIEW
12.2 MAMMALIAN CELLS
12.3 PLANTS
12.4 FUNGI
12.5 VIRUS
12.6 BACTERIA
13 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPES OF MOLECULE
13.1 OVERVIEW
13.2 PLASMID DNA
13.3 SMALL INTERFERING RNA (SIRNA)
13.4 PROTEINS
13.5 DNA OLIGONUCLEOTIDES
13.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)
13.7 OTHERS
14 ASIA-PACIFIC TRANSFECTION MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 BY TYPE
14.2.1 IN VITRO APPLICATION
14.2.1.1 Gene Expression
14.2.1.2 RNA Interference
14.2.2 IN VIVO APPLICATION
14.2.2.1 Gene Therapy
14.2.2.2 Cellular-Based Therapy
14.2.3 BIOPRODUCTION
14.2.3.1 Antibody/Protein Production
14.2.3.2 Virus Production
14.2.4 OTHERS
14.3 BY INDUSTRY
14.3.1 SYNTHETIC BIOLOGY
14.3.1.1 Biopharma
14.3.1.2 Monoclonal Antibodies (mAbs)
14.3.1.3 Recombinant Proteins
14.3.1.4 Biofuels
14.3.1.5 Cell Line Development
14.3.1.6 Flavors & Fragrances
14.3.1.7 Enzyme Engineering & Production
14.3.1.8 Specialty Chemicals
14.3.2 AGRICULTURE
14.3.3 OTHERS
15 ASIA-PACIFIC TRANSFECTION MARKET, BY STAGES
15.1 OVERVIEW
15.2 RESEARCH
15.3 PRECLINICAL
15.4 CLINICAL PHASES
15.5 COMMERCIAL
16 ASIA-PACIFIC TRANSFECTION MARKET, BY END USER
16.1 OVERVIEW
16.2 BIOPHARMA
16.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)
16.4 CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS)
16.5 ACADEMIA
16.6 HOSPITALS
16.7 CLINICAL LABS
16.8 OTHERS
17 ASIA-PACIFIC TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT TENDERS
17.3 RETAIL SALES
17.4 OTHERS
18 ASIA-PACIFIC TRASNFECTION MARKET, BY GEOGRAPHY
18.1 ASIA PACIFIC
18.1.1 CHINA
18.1.2 JAPAN
18.1.3 INDIA
18.1.4 AUSTRALIA
18.1.5 SOUTH KOREA
18.1.6 SINGAPORE
18.1.7 THAILAND
18.1.8 MALAYSIA
18.1.9 INDONESIA
18.1.10 PHILIPPINES
18.1.11 REST OF ASIA- PACIFIC
19 ASIA-PACIFIC TRANSFECTION MARKET: COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
20 SWOT ANALYSIS
21 COMPANY PROFILE
21.1 THERMOFISHER SCIENTIFIC INC.
21.1.1 COMPANY SNAPSHOT
21.1.2 REVENUE ANALYSIS
21.1.3 COMPANY SHARE ANALYSIS
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENTS
21.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
21.2.1 COMPANY SNAPSHOT
21.2.2 REVENUE ANALYSIS
21.2.3 COMAPYN SHARE ANALYSIS
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENTS
21.3 QIAGEN
21.3.1 COMPANY SNAPSHOT
21.3.2 REVENUE ANALYSIS
21.3.3 COMPANY SHARE ANALYSIS
21.3.4 PRODUCT PORTFOLIO
21.3.5 RECENT DEVELOPMENTS
21.4 PROMEGA CORPORATION
21.4.1 COMPANY SNAPSHOT
21.4.2 COMPANY SHARE ANALYSIS
21.4.3 PRODUCT PORTFOLIO
21.4.4 RECENT DEVELOPMENTS
21.5 TAKARA BIO INC.
21.5.1 COMPANY SNAPSHOT
21.5.2 REVENUE ANALYSIS
21.5.3 COMPANY SHARE ANALYSIS
21.5.4 PRODUCT PORTFOLIO
21.5.5 RECENT DEVELOPMENTS
21.6 BIO-RAD LABORATORIES, INC.
21.6.1 COMPANY SNAPSHOT
21.6.2 REVENUE ANANLYSIS
21.6.3 PRODUCT PORTFOLIO
21.6.4 RECENT DEVELOPMENT
21.7 LONZA
21.7.1 COMPANY SNAPSHOT
21.7.2 REVENUE ANANLYSIS
21.7.3 PRODUCT PORTFOLIO
21.7.4 RECENT DEVELOPMENTS
21.8 CYTIVA
21.8.1 COMPANY SNAPSHOT
21.8.2 PRODUCT PORTFOLIO
21.8.3 RECENT DEVELOPMENTS
21.9 ALTOGEN BIOSYSTEMS
21.9.1 COMPANY SNAPSHOT
21.9.2 PRODUCT PORTFOLIO
21.9.3 RECENT DEVELOPMENTS
21.1 AMYRIS
21.10.1 COMPANY SNAPSHOT
21.10.2 REVENUE ANALYSIS
21.10.3 PRODUCT PORTFOLIO
21.10.4 RECENT DEVELOPMENTS
21.11 APPLIED BIOLOGICAL MATERIALS INC. (ABM)
21.11.1 COMPANY SNAPSHOT
21.11.2 PRODUCT PORTFOLIO
21.11.3 RECENT DEVELOPMENT
21.12 AUTOLUS
21.12.1 COMPANY SNAPSHOT
21.12.2 PRODUCT PORTFOLIO
21.12.3 RECENT DEVELOPMENTS
21.13 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)
21.13.1 COMPANY SNAPSHOT
21.13.2 REVENUE ANALYSIS
21.13.3 PRODUCT PORTFOLIO
21.13.4 RECENT DEVELOPMENT
21.14 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
21.14.1 COMPANY SNAPSHOT
21.14.2 REVENUE ANALYSIS
21.14.3 PRODUCT PORTFOLIO
21.14.4 RECENT DEVELOPMENTS
21.15 CODEXIS
21.15.1 COMPANY SNAPSHOT
21.15.2 REVENUE ANALYSIS
21.15.3 PRODUCT PORTFOLIO
21.15.4 RECENT DEVELOPMENTS
21.16 CONAGEN, INC.
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENTS
21.17 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)
21.17.1 COMPANY SNAPSHOT
21.17.2 REVENUE ANANLYSIS
21.17.3 PRODUCT PORTFOLIO
21.17.4 RECENT DEVELOPMENT
21.18 GENLANTIS INC.
21.18.1 COMPANY SNAPSHOT
21.18.2 PRODUCT PORTFOLIO
21.18.3 RECENT DEVELOPMENTS
21.19 GENO TECHNOLOGY INC., USA
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENTS
21.2 GINKGO BIOWORKS
21.20.1 COMPANY SNAPSHOT
21.20.2 PRODUCT PORTFOLIO
21.20.3 RECENT DEVELOPMENTS
21.21 IMPOSSIBLE FOODS INC.
21.21.1 COMPANY SNAPSHOT
21.21.2 PRODUCT PORTFOLIO
21.21.3 RECENT DEVELOPMENTS
21.22 MAXCYTE, INC.
21.22.1 COMPANY SNAPSHOT
21.22.2 REVENUE ANALYSIS
21.22.3 PRODUCT PORTFOLIO
21.22.4 RECENT DEVELOPMENTS
21.23 MERCK KGAA
21.23.1 COMPANY SNAPSHOT
21.23.2 REVENUE ANALYSIS
21.23.3 PRODUCT PORTFOLIO
21.23.4 RECENT DEVELOPMENTS
21.24 MIRUS BIO LLC.
21.24.1 COMPANY SNAPSHOT
21.24.2 PRODUCT PORTFOLIO
21.24.3 RECENT DEVELOPMENTS
21.25 ORIGENE TECHNOLOGIES, INC.
21.25.1 COMPANY SNAPSHOT
21.25.2 PRODUCT PORTFOLIO
21.25.3 RECENT DEVELOPMENTS
21.26 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)
21.26.1 COMPANY SNAPSHOT
21.26.2 REVENUE ANANLYSIS
21.26.3 PRODUCT PORTFOLIO
21.26.4 RECENT DEVELOPMENTS
21.27 POLYPLUS TRANSFECTION
21.27.1 COMPANY SNAPSHOT
21.27.2 PRODUCT PORTFOLIO
21.27.3 RECENT DEVELOPMENTS
21.28 POSEIDA THERAPEUTICS, INC.
21.28.1 COMPANY SNAPSHOT
21.28.2 PRODUCT PORTFOLIO
21.28.3 RECENT DEVELOPMENTS
21.29 R&D SYSTEMS, INC.
21.29.1 COMPANY SNAPSHOT
21.29.2 PRODUCT PORTFOLIO
21.29.3 RECENT DEVELOPMENT
21.3 SBS GENETECH
21.30.1 COMPANY SNAPSHOT
21.30.2 PRODUCT PORTFOLIO
21.30.3 RECENT DEVELOPMENTS
21.31 SIGNAGEN LABORATORIES
21.31.1 COMPANY SNAPSHOT
21.31.2 PRODUCT PORTFOLIO
21.31.3 RECENT DEVELOPMENTS
21.32 TWIST BIOSCIENCE
21.32.1 COMPANY SNAPSHOT
21.32.2 REVENUE ANALYSIS
21.32.3 PRODUCT PORTFOLIO
21.32.4 RECENT DEVELOPMENTS
21.33 VERVE THERAPEUTICS, INC.
21.33.1 COMPANY SNAPSHOT
21.33.2 PRODUCT PORTFOLIO
21.33.3 RECENT DEVELOPMENTS
21.34 ZYMERGEN INC.
21.34.1 COMPANY SNAPSHOT
21.34.2 PRODUCT PORTFOLIO
21.34.3 RECENT DEVELOPMENTS
22 QUESTIONNAIRE
23 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 LIST OF APPROVED ANTIBODIES PRODUCED IN CHO CELLS
TABLE 2 EU DIRECTIVES AND REGULATIONS RELATED TO CLINICAL TRIALS INVOLVING GTMPS
TABLE 3 GOVERNMENT ENTITIES THAT ARE IN CHARGE OF TYPE 2 USES
TABLE 4 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC TRANSIENT TRANSFECTION IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 6 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 12 ASIA-PACIFIC NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 16 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 19 ASIA-PACIFIC NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 23 ASIA-PACIFIC VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC SOFTWARE BY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC MAMMALIAN CELLS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC PLANTS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC FUNGI IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC VIRUS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC PLASMID DNA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC PROTEINS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC DNA OLIGONUCLEOTIDES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFICTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC IN VITRO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC IN VIVO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC BIOPRODUCTION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 55 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 ASIA-PACIFIC OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 57 ASIA-PACIFIC TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 ASIA-PACIFIC SYNTHETIC BIOLOGY IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 59 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 ASIA-PACIFIC AGRICULTURE IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 61 ASIA-PACIFIC OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 62 NORTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 63 ASIA-PACIFIC RESEARCH IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 64 ASIA-PACIFIC PRE-CLINICAL IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 65 ASIA-PACIFIC CLINICAL PHASES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 66 ASIA-PACIFIC COMMERCIAL IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 67 NORTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 ASIA-PACIFIC BIOPHARMA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 69 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS (CROS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 70 ASIA-PACIFIC CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 71 ASIA-PACIFIC ACADEMIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 72 ASIA-PACIFIC HOSPITALS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 73 ASIA-PACIFIC CLINICAL LABS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 74 ASIA-PACIFIC OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 75 NORTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 76 ASIA-PACIFIC DIRECT TENDER IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 77 ASIA-PACIFIC RETAIL SALES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 78 ASIA-PACIFIC OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 79 ASIA- PACIFIC TRANSFECTION MARKET, BY REGION, 2018-2028 (USD MILLION)
TABLE 80 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 81 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 ASIA-PACIFIC TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 ASIA-PACIFIC STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 84 ASIA-PACIFIC STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 ASIA-PACIFIC TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 86 ASIA-PACIFIC NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 87 ASIA-PACIFIC CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 88 ASIA-PACIFIC PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 89 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 90 ASIA-PACIFIC CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 91 ASIA-PACIFIC NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 92 ASIA-PACIFIC CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 93 ASIA-PACIFIC PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 94 ASIA-PACIFIC VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 95 ASIA-PACIFIC TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 96 ASIA-PACIFIC REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 97 ASIA-PACIFIC CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 98 ASIA-PACIFIC LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 99 ASIA-PACIFIC NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 100 ASIA-PACIFIC CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 101 ASIA-PACIFIC KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 102 ASIA-PACIFIC NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 103 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 104 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 105 ASIA-PACIFIC ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 106 ASIA-PACIFIC TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 107 ASIA-PACIFIC TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 108 ASIA-PACIFICTRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 109 ASIA-PACIFIC IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 ASIA-PACIFIC IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 111 ASIA-PACIFIC BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 ASIA-PACIFIC TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 ASIA-PACIFIC SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 114 ASIA-PACIFIC TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 115 ASIA-PACIFIC TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 116 ASIA-PACIFIC TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 117 CHINA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 118 CHINA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 CHINA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 120 CHINA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 121 CHINA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 122 CHINA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 123 CHINA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 124 CHINA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 125 CHINA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 126 CHINA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 127 CHINA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 128 CHINA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 129 CHINA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 130 CHINA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 131 CHINA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 132 CHINA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 133 CHINA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 134 CHINA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 135 CHINA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 136 CHINA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 137 CHINA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 138 CHINA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 139 CHINA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 140 CHINA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 141 CHINA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 142 CHINA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 143 CHINA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 144 CHINA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 145 CHINA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 146 CHINA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 147 CHINA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 148 CHINA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 149 CHINA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 150 CHINA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 151 CHINA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 152 CHINA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 153 CHINA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 154 JAPAN TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 155 JAPAN TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 156 JAPAN TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 157 JAPAN STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 158 JAPAN STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 159 JAPAN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 160 JAPAN NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 161 JAPAN CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 162 JAPAN PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 163 JAPAN VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 164 JAPAN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 165 JAPAN NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 166 JAPAN CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 167 JAPAN PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 168 JAPAN VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 169 JAPAN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 170 JAPAN REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 171 JAPAN CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 172 JAPAN LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 173 JAPAN NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 174 JAPAN CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 175 JAPAN KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 176 JAPAN NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 177 JAPAN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 178 JAPAN INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 179 JAPAN ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 180 JAPAN TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 181 JAPAN TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 182 JAPAN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 183 JAPAN IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 184 JAPAN IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 185 JAPAN BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 186 JAPAN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 187 JAPAN SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 188 JAPAN TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 189 JAPAN TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 190 JAPAN TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 191 INDIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 192 INDIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 193 INDIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 194 INDIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 195 INDIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 196 INDIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 197 INDIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 198 INDIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 199 INDIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 200 INDIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 201 INDIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 202 INDIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 203 INDIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 204 INDIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 205 INDIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 206 INDIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 207 INDIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 208 INDIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 209 INDIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 210 INDIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 211 INDIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 212 INDIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 213 INDIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 214 INDIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 215 INDIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 216 INDIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 217 INDIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 218 INDIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 219 INDIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 220 INDIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 221 INDIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 222 INDIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 223 INDIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 224 INDIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 225 INDIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 226 INDIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 227 INDIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 228 AUSTRALIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 229 AUSTRALIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 230 AUSTRALIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 231 AUSTRALIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 232 AUSTRALIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 233 AUSTRALIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 234 AUSTRALIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 235 AUSTRALIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 236 AUSTRALIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 237 AUSTRALIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 238 AUSTRALIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 239 AUSTRALIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 240 AUSTRALIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 241 AUSTRALIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 242 AUSTRALIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 243 AUSTRALIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 244 AUSTRALIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 245 AUSTRALIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 246 AUSTRALIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 247 AUSTRALIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 248 AUSTRALIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 249 AUSTRALIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 250 AUSTRALIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 251 AUSTRALIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 252 AUSTRALIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 253 AUSTRALIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 254 AUSTRALIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 255 AUSTRALIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 256 AUSTRALIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 257 AUSTRALIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 258 AUSTRALIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 259 AUSTRALIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 260 AUSTRALIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 261 AUSTRALIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 262 AUSTRALIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 263 AUSTRALIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 264 AUSTRALIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 265 SOUTH KOREA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 266 SOUTH KOREA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 267 SOUTH KOREA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 268 SOUTH KOREA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 269 SOUTH KOREA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 270 SOUTH KOREA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 271 SOUTH KOREA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 272 SOUTH KOREA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 273 SOUTH KOREA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 274 SOUTH KOREA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 275 SOUTH KOREA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 276 SOUTH KOREA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 277 SOUTH KOREA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 278 SOUTH KOREA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 279 SOUTH KOREA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 280 SOUTH KOREA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 281 SOUTH KOREA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 282 SOUTH KOREA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 283 SOUTH KOREA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 284 SOUTH KOREA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 285 SOUTH KOREA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 286 SOUTH KOREA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 287 SOUTH KOREA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 288 SOUTH KOREA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 289 SOUTH KOREA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 290 SOUTH KOREA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 291 SOUTH KOREA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 292 SOUTH KOREA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 293 SOUTH KOREA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 294 SOUTH KOREA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 295 SOUTH KOREA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 296 SOUTH KOREA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 297 SOUTH KOREA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 298 SOUTH KOREA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 299 SOUTH KOREA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 300 SOUTH KOREA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 301 SOUTH KOREA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 302 SINGAPORE TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 303 SINGAPORE TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 304 SINGAPORE TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 305 SINGAPORE STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 306 SINGAPORE STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 307 SINGAPORE TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 308 SINGAPORE NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 309 SINGAPORE CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 310 SINGAPORE PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 311 SINGAPORE VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 312 SINGAPORE CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 313 SINGAPORE NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 314 SINGAPORE CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 315 SINGAPORE PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 316 SINGAPORE VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 317 SINGAPORE TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 318 SINGAPORE REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 319 SINGAPORE CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 320 SINGAPORE LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 321 SINGAPORE NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 322 SINGAPORE CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 323 SINGAPORE KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 324 SINGAPORE NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 325 SINGAPORE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 326 SINGAPORE INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 327 SINGAPORE ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 328 SINGAPORE TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 329 SINGAPORE TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 330 SINGAPORE TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 331 SINGAPORE IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 332 SINGAPORE IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 333 SINGAPORE BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 334 SINGAPORE TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 335 SINGAPORE SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 336 SINGAPORE TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 337 SINGAPORE TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 338 SINGAPORE TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 339 THAILAND TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 340 THAILAND TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 341 THAILAND TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 342 THAILAND STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 343 THAILAND STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 344 THAILAND TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 345 THAILAND NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 346 THAILAND CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 347 THAILAND PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 348 THAILAND VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 349 THAILAND CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 350 THAILAND NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 351 THAILAND CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 352 THAILAND PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 353 THAILAND VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 354 THAILAND TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 355 THAILAND REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 356 THAILAND CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 357 THAILAND LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 358 THAILAND NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 359 THAILAND CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 360 THAILAND KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 361 THAILAND NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 362 THAILAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 363 THAILAND INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 364 THAILAND ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 365 THAILAND TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 366 THAILAND TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 367 THAILAND TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 368 THAILAND IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 369 THAILAND IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 370 THAILAND BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 371 THAILAND TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 372 THAILAND SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 373 THAILAND TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 374 THAILAND TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 375 THAILAND TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 376 MALAYSIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 377 MALAYSIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 378 MALAYSIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 379 MALAYSIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 380 MALAYSIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 381 MALAYSIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 382 MALAYSIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 383 MALAYSIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 384 MALAYSIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 385 MALAYSIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 386 MALAYSIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 387 MALAYSIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 388 MALAYSIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 389 MALAYSIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 390 MALAYSIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 391 MALAYSIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 392 MALAYSIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 393 MALAYSIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 394 MALAYSIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 395 MALAYSIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 396 MALAYSIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 397 MALAYSIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 398 MALAYSIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 399 MALAYSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 400 MALAYSIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 401 MALAYSIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 402 MALAYSIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 403 MALAYSIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 404 MALAYSIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 405 MALAYSIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 406 MALAYSIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 407 MALAYSIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 408 MALAYSIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 409 MALAYSIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 410 MALAYSIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 411 MALAYSIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 412 MALAYSIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 413 MALAYSIA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 414 INDONESIA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 415 INDONESIA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 416 INDONESIA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 417 INDONESIA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 418 INDONESIA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 419 INDONESIA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 420 INDONESIA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 421 INDONESIA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 422 INDONESIA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 423 INDONESIA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 424 INDONESIA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 425 INDONESIA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 426 INDONESIA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 427 INDONESIA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 428 INDONESIA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 429 INDONESIA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 430 INDONESIA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 431 INDONESIA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 432 INDONESIA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 433 INDONESIA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 434 INDONESIA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 435 INDONESIA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 436 INDONESIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 437 INDONESIA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 438 INDONESIA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 439 INDONESIA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 440 INDONESIA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 441 INDONESIA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 442 INDONESIA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 443 INDONESIA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 444 INDONESIA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 445 INDONESIA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 446 INDONESIA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 447 INDONESIA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 448 INDONESIA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 449 INDONESIA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 450 PHILIPPINES TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 451 PHILIPPINES TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 452 PHILIPPINES TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 453 PHILIPPINES STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 454 PHILIPPINES STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 455 PHILIPPINES TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 456 PHILIPPINES NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 457 PHILIPPINES CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 458 PHILIPPINES PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 459 PHILIPPINES VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 460 PHILIPPINES CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 461 PHILIPPINES NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 462 PHILIPPINES CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 463 PHILIPPINES PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 464 PHILIPPINES VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)
TABLE 465 PHILIPPINES TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 466 PHILIPPINES REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 467 PHILIPPINES CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 468 PHILIPPINES LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 469 PHILIPPINES NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 470 PHILIPPINES CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 471 PHILIPPINES KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 472 PHILIPPINES NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 473 PHILIPPINES INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 474 PHILIPPINES INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)
TABLE 475 PHILIPPINES ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)
TABLE 476 PHILIPPINES TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)
TABLE 477 PHILIPPINES TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)
TABLE 478 PHILIPPINES TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 479 PHILIPPINES IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 480 PHILIPPINES IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 481 PHILIPPINES BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 482 PHILIPPINES TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 483 PHILIPPINES SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 484 PHILIPPINES TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 485 PHILIPPINES TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 486 PHILIPPINES TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 487 REST OF ASIA- PACIFIC TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC TRANSFECTION MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC TRANSFECTION MARKET : DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC TRANSFECTION MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC TRANSFECTION MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC TRANSFECTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC TRANSFECTION MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC TRANSFECTION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC TRANSFECTION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 ASIA-PACIFIC TRANSFECTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC TRANSFECTION MARKET: SEGMENTATION
FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE ASIA-PACIFIC TRANSFECTION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC TRANSFECTION MARKET IN 2021 & 2028
FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC TRANSFECTION MARKET
FIGURE 16 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE, 2020
FIGURE 17 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 18 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 19 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, 2020
FIGURE 21 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION)
FIGURE 22 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028)
FIGURE 23 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, 2020
FIGURE 25 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, 2020-2028 (USD MILLION)
FIGURE 26 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, CAGR (2021-2028)
FIGURE 27 ASIA-PACIFIC TRANSFECTION MARKET: BY METHODS, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC TRANSFECTION MARKET: BY PRODUCT, 2020
FIGURE 29 ASIA-PACIFIC TRANSFECTION MARKET: BY PRODUCT, 2020-2028 (USD MILLION)
FIGURE 30 ASIA-PACIFIC TRANSFECTION MARKET: BY PRODUCT, CAGR (2021-2028)
FIGURE 31 ASIA-PACIFIC TRANSFECTION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC TRANSFECTION MARKET: BY ORGANISM, 2020
FIGURE 33 ASIA-PACIFIC TRANSFECTION MARKET: BY ORGANISM, 2020-2028 (USD MILLION)
FIGURE 34 ASIA-PACIFIC TRANSFECTION MARKET: BY ORGANISM, CAGR (2021-2028)
FIGURE 35 ASIA-PACIFIC TRANSFECTION MARKET: BY ORGANISM, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020
FIGURE 37 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPES OF MOLECULE, 2020-2028 (USD MILLION)
FIGURE 38 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPES OF MOLECULE, CAGR (2021-2028)
FIGURE 39 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPES OF MOLECULE LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC TRANSFECTION MARKET: BY APPLICATION, 2020
FIGURE 41 ASIA-PACIFIC TRANSFECTION MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 42 ASIA-PACIFIC TRANSFECTION MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 43 ASIA-PACIFIC TRANSFECTION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC TRANSFECTION MARKET: BY STAGES, 2020
FIGURE 45 ASIA-PACIFIC TRANSFECTION MARKET: BY STAGES, 2020-2028 (USD MILLION)
FIGURE 46 ASIA-PACIFIC TRANSFECTION MARKET: BY STAGES, CAGR (2021-2028)
FIGURE 47 ASIA-PACIFIC TRANSFECTION MARKET: BY STAGES, LIFELINE CURVE
FIGURE 48 ASIA-PACIFIC TRANSFECTION MARKET: BY END USER, 2020
FIGURE 49 ASIA-PACIFIC TRANSFECTION MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 50 ASIA-PACIFIC TRANSFECTION MARKET: BY END USER, CAGR (2021-2028)
FIGURE 51 ASIA-PACIFIC TRANSFECTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 52 ASIA-PACIFIC TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 53 ASIA-PACIFIC TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 54 ASIA-PACIFIC TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 55 ASIA-PACIFIC TRANSFECTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 56 ASIA-PACIFIC TRANSFECTION MARKET: SNAPSHOT (2020)
FIGURE 57 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2020)
FIGURE 58 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 59 ASIA-PACIFIC TRANSFECTION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 60 ASIA-PACIFIC TRANSFECTION MARKET: BY TYPE (2021-2028)
FIGURE 1 ASIA-PACIFIC TRANSFECTION MARKET: COMPANY SHARE 2020 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
